MedPath

Colchicine Has Anti-diabetic Effect

Completed
Conditions
Treatment Adherence
Interventions
Registration Number
NCT04377321
Lead Sponsor
Ministry of Health and Population, Egypt
Brief Summary

Colchicine has antidiabetic effect and may be an option for type 2 diabetes management

Detailed Description

Observational cohort prospective study with following of 150 newly diagnosed type 2 diabetes patients who were in 3 groups, had been monitored in a private clinic, each group 50 patients number, with 30 females and 20 males after written consent from all patients. The ages of all patients were between 35 and 55 years.

The aim of this study was to evaluate colchicine effect on A1C of newly diagnosed type2 diabetes compared to the metformin and control group on diet only.

The first group patients received colchicine 0.5twice daily for 6 months, the second group received metformin 1gm twice daily, the third group patients were on diet only. During the period of treatment, the investigators followed the patients if there were side effects of the drugs used. No side effects were monitored during the period of treatment except for gastric upset in some patients using metformin

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
150
Inclusion Criteria
  • type 2 diabetes newly diagnosed age 35- 55 years
Exclusion Criteria
  • severe anemia hypothyroidism and hyperthyroidism moderate to severe liver or kidney disease

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
group 1 on cochicineColchicine TabletsThe first group patients received colchicine 0.5 twice daily for 6 months
group 3 controlColchicine Tabletsthe third group patients were on diet only for 6 months
group 2 on glucophage 1 gm twice dailyColchicine Tabletssecond group received glucophage 1gm twice daily for 6 months
Primary Outcome Measures
NameTimeMethod
colchicine for treatment of type diabetes patients6 months

colchicine tablets .5 mg twice daily for 6 months

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Mahmoud Younis

🇪🇬

Cairo, Egypt

© Copyright 2025. All Rights Reserved by MedPath